COVISHIELD
- World
AstraZeneca starts global withdrawal of COVID-19 vaccine
London: UK-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as ‘Covishield’ in partnership with Serum Institute of India, days after it admitted to…
- India
Plea in SC seeks medical panel to examine Covishield side effects
New Delhi: A plea has been filed in the Supreme Court seeking the formation of a medical panel of experts under the supervision of a retired judge of the apex court to…
- India
Covishield study finds risk of blood clot post vaccination
London: People with blood group O have an increased risk of cerebral venous thrombosis (CVT), or venous stroke, after taking the Oxford-AstraZeneca vaccine, administered as Covishield in India, claimed a large study.…
- India
No link between Covid vaccines used in India and heart attack risk: Study
New Delhi: There is no association between the Covid-19 vaccines used in India — Covishield and Covaxin — and increase in the risk of heart attacks, according to an observational study which…
- India
Serum Institute of India restarts manufacturing of Covishield
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said…
- Delhi
DGCI approves market authorisation of Serum Institute’s Covovax as booster dose
Delhi: The Drugs Controller General of India (DCGI) has approved the market authorisation of Serum Institute of India’s (SII) COVID-19 vaccine Covovax as a heterologous booster dose. This vaccine can be taken…
- Hyderabad
Vaccination centers in Hyderabad see sudden rush amid COVID fears
Hyderabad: Amid growing concerns over COVID-19, people are seen rushing to vaccination centers in Hyderabad. Precautionary doses are in high demand in the city as most people are already vaccinated with doses…
- India
Corbevax recommended as booster for adults vaccinated with Covishield, Covaxin
New Delhi: A government panel on Covid immunisation has recommended allowing Biological E’s Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin, official sources said on Tuesday.…
- Hyderabad
Hyderabad based Corbevax gets DGCI nod as COVID-19 booster for 18+
New Delhi: Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous Covid-19…
- Top Stories
SII, Bharat Biotech cut prices of COVID-19 vaccines for pvt hospitals to Rs 225
New Delhi: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs…
- India
Covid precaution dose for 18+ age group at private vaccination centres from Apr 10
New Delhi: Precaution dose of COVID-19 vaccines will be available to all aged above 18 years at private vaccination centres from April 10, the Union Health Ministry announced on Friday. According to…
- India
Serum Institute’s Covishield precaution dose priced at Rs 600 per shot
New Delhi: Vaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.…
- India
Reduce Covishield dose gap, recommends panel
New Delhi: The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of Covid vaccine Covishield to 8 to 16 weeks in view…
